Clinical Trial Update: The SPOT-HPV Study

View source ↗

Summary

Clinical trial SPOT-HPV study has completed; this update does not report results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection
• Oropharyngeal Squamous Cell Carcinoma

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: HPV Infection, HPV Positive Oropharyngeal Squamous Cell Carcinoma | Status: COMPLETED